Jim Simons’s Annovis Bio ANVS Stock Holding History

Jim Simons’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Buy	1,002,200 +654,600	+188%	+$1.27M	﹤0.01%	1994
2026 Q1	$775K	Buy	+347,600	New	+$953K	﹤0.01%	2399
2025 Q2	–	Sell	-21,800	Closed	-$32.7K	–	3537
2025 Q1	$32.7K	Buy	+21,800	New	+$66.7K	﹤0.01%	3333
2022 Q3	–	Sell	-16,700	Closed	-$189K	–	4002
2022 Q2	$189K	Sell	16,700 -6,497	-28%	-$71K	﹤0.01%	3669
2022 Q1	$310K	Buy	23,197 +12,697	+121%	+$183K	﹤0.01%	3459
2021 Q4	$185K	Buy	+10,500	New	+$271K	﹤0.01%	3537
2021 Q2	–	Sell	-19,900	Closed	-$555K	–	3430
2021 Q1	$555K	Buy	+19,900	New	+$426K	﹤0.01%	2871
2020 Q4	–	Sell	-20,615	Closed	-$99K	–	3362
2020 Q3	$99K	Buy	+20,615	New	+$110K	﹤0.01%	3215

Other funds holding ANVS

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jim Simons's ANVS Position: Q2 2026 in Review

Jim Simons increased its Annovis Bio (ANVS) stake by 188% in Q2 2026, buying an estimated $1.27M and bringing the position to 1,002,200 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

Jim Simons first reported a position in ANVS in Q3 2020 and has held it in 8 quarters since. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Jim Simons held 1,002,200 shares of Annovis Bio worth $1.86M as of Q2 2026.
Jim Simons bought 654,600 Annovis Bio shares in Q2 2026, an estimated $1.27M.
Annovis Bio made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #1994 holding.
Jim Simons first reported a position in Annovis Bio in Q3 2020 and has held it in 8 quarters since.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.